awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33729158-4567F2ED-31D3-464F-A7BE-6E037CD4A898
Q33729158-4567F2ED-31D3-464F-A7BE-6E037CD4A898
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33729158-4567F2ED-31D3-464F-A7BE-6E037CD4A898
Phase I study of valspodar (PSC-833) with mitoxantrone and etoposide in refractory and relapsed pediatric acute leukemia: a report from the Children's Oncology Group.
P2860
Q33729158-4567F2ED-31D3-464F-A7BE-6E037CD4A898
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33729158-4567F2ED-31D3-464F-A7BE-6E037CD4A898
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
486f34a3ab8fd61df6c8ad67e0fbc5bda2f7e67d
P2860
Combined action of PSC 833 (Valspodar), a novel MDR reversing agent, with mitoxantrone, etoposide and cytarabine in poor-prognosis acute myeloid leukemia.